Macular Degeneration Research
Your browser cannot view frames. The same
information is provided in our no-frames
. The no-frames section is also designed to be accessible for person's
with disabilities.
Home Page
Photodynamic therapy is a new treatment that
has just been approved by the Food and Drug Administration for its use in
patients with "wet" macular degeneration.
In this procedure, a light-sensitive drug
called Visudyne is injected into the patient's bloodstream. The drug circulates
throughout the blood vessels, including the abnormal vessels growing beneath
the eye's retina. Once the drug has had time to permeate the tiny vessels
beneath the retina, the light of a low-intensity laser is shined into the
eye. The Visudyne absorbs the light, destroying the abnormal or leaky vessels.
Photodynamic therapy has an advantage over the currently used photocoagulation
technique because less heat is required from the laser, meaning that healthy
tissues around the site of the procedure receive less "collateral damage.
macular degeneration, What's
New, science, What's New, science, news, news, updates, treatment, research, charity, blindness, research grants,information, booklets, support, blindness, eye, American Health Assistance Foundation,macular degeneration,updates, treatment,
research, charity, research grants, information, booklets, support,
eye